Literature DB >> 28459213

Fibroblast growth factor receptors in breast cancer.

Shuwei Wang1, Zhongyang Ding1.   

Abstract

Fibroblast growth factor receptors are growth factor receptor tyrosine kinases, exerting their roles in embryogenesis, tissue homeostasis, and development of breast cancer. Recent genetic studies have identified some subtypes of fibroblast growth factor receptors as strong genetic loci associated with breast cancer. In this article, we review the recent epidemiological findings and experiment results of fibroblast growth factor receptors in breast cancer. First, we summarized the structure and physiological function of fibroblast growth factor receptors in humans. Then, we discussed the common genetic variations in fibroblast growth factor receptors that affect breast cancer risk. In addition, we also introduced the potential roles of each fibroblast growth factor receptors isoform in breast cancer. Finally, we explored the potential therapeutics targeting fibroblast growth factor receptors for breast cancer. Based on the biological mechanisms of fibroblast growth factor receptors leading to the pathogenesis in breast cancer, targeting fibroblast growth factor receptors may provide new opportunities for breast cancer therapeutic strategies.

Entities:  

Keywords:  Fibroblast growth factor receptor; breast cancer; genetics; therapeutic strategy

Mesh:

Substances:

Year:  2017        PMID: 28459213     DOI: 10.1177/1010428317698370

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  16 in total

1.  TNFAIP3 promotes ALDH-positive breast cancer stem cells through FGFR1/MEK/ERK pathway.

Authors:  Wanru Feng; Mengdi Gao; Mao Yang; Xue Li; Zhonglin Gan; Ting Wu; Yan Lin; Tao He
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

Review 2.  A Tale of Two Cancers: A Current Concise Overview of Breast and Prostate Cancer.

Authors:  Franklyn De Silva; Jane Alcorn
Journal:  Cancers (Basel)       Date:  2022-06-15       Impact factor: 6.575

3.  Caveolin-1 and -2 regulate cell motility in castration-resistant prostate cancer.

Authors:  Toyoharu Kamibeppu; Koji Yamasaki; Kozue Nakahara; Takahiro Nagai; Naoki Terada; Hiromasa Tsukino; Shoichiro Mukai; Toshiyuki Kamoto
Journal:  Res Rep Urol       Date:  2018-10-03

4.  FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells.

Authors:  Ming Zhao; Ming-Lei Zhuo; Xiaofeng Zheng; Xiaoping Su; Funda Meric-Bernstam
Journal:  Oncotarget       Date:  2019-01-01

5.  Construction and characterization of immunoliposomes targeting fibroblast growth factor receptor 3.

Authors:  Zhong Zheng; Haotian Ji; Wenbo Zong; Qiuju Ran; Xinxin Wang; Xi Yang; Zhuo Zhao; Chengjun Yang; Yechen Xiao
Journal:  AMB Express       Date:  2019-09-18       Impact factor: 3.298

6.  The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma.

Authors:  Wenjing Zhang; Yaxing Zhou; Chao Li; Shanshan Xu; Mengyan Li; Wenying Liu; Yuqing Ma; Hui Wang
Journal:  Anal Cell Pathol (Amst)       Date:  2020-12-11       Impact factor: 2.916

7.  Assessing the functional relevance of splice isoforms.

Authors:  Fernando Pozo; Laura Martinez-Gomez; Thomas A Walsh; José Manuel Rodriguez; Tomas Di Domenico; Federico Abascal; Jesús Vazquez; Michael L Tress
Journal:  NAR Genom Bioinform       Date:  2021-05-22

8.  TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer.

Authors:  María Paz Saldías; Diego Maureira; Octavio Orellana-Serradell; Ian Silva; Boris Lavanderos; Pablo Cruz; Camila Torres; Mónica Cáceres; Oscar Cerda
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

9.  Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process.

Authors:  Alicia González-González; Alicia González; Noemi Rueda; Carolina Alonso-González; Javier Menéndez Menéndez; Carlos Martínez-Campa; Stefania Mitola; Samuel Cos
Journal:  Sci Rep       Date:  2020-03-16       Impact factor: 4.379

10.  miR-671-5p Blocks The Progression Of Human Esophageal Squamous Cell Carcinoma By Suppressing FGFR2.

Authors:  Xiaoyan Li; Changjun Nie; Baoqing Tian; Xuan Tan; Wei Han; Jiakang Wang; Yuan Jin; Yadan Li; Xinyuan Guan; An Hong; Xiaojia Chen
Journal:  Int J Biol Sci       Date:  2019-07-21       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.